A clinical trial for psychedelic therapy using music is set to begin in London this summer, The Times reports.
The centre, which is managed by the pharmaceutical start-up Clerkenwell Health, will be Europe’s first commercial environment for clinical studies of psychedelic substances.
Patients will have a controlled environment to listen to music while taking drugs including magic mushrooms, LSD, ketamine and MDMA.
Magic mushrooms could be as effective as the most…
